Research Article

Ternary nanocomposite potentiates the lysophosphatidic acid effect on human osteoblast (MG63) maturation

*Author for correspondence:

Department of Surgery, Faculty of Veterinary Medicine, Alexandria University, Alexandria, 22785, Egypt

Department of Electrical & Electronic Information Engineering, Toyohashi University of Technology, 1–1 Hibarigaoka, Tempaku-Cho, Toyohashi, Aichi, 441–8580, Japan

Search for more papers by this author

Jason Peter Mansell

**Author for correspondence:

E-mail Address: jason.mansell@uwe.ac.uk

Department of Applied Sciences, University of the West of England, Frenchay Campus, Coldharbour Lane, Bristol, BS16 1QY, UK

Search for more papers by this author

Published Online:10 Oct 2023https://doi.org/10.2217/nnm-2023-0117

View article

Abstract

Aim: This study aimed to investigate the potential of ternary nanocomposite (TNC) to support MG63 osteoblast maturation to EB1089-(3S)1-fluoro-3-hydroxy-4-(oleoyloxy)butyl-1-phosphonate (FHBP) cotreatment. Materials & methods: Binary (P25/reduced graphene oxide [rGO]) nanocomposite was prepared, and silver (Ag) nanoparticles were loaded onto the surface to form TNC (P25/rGO/Ag). The influence of TNC on proliferation, alkaline phosphatase activity and osteogenic gene expression was evaluated in a model of osteoblast maturation wherein MG63 were costimulated with EB1089 and FHBP. Results: TNC had no cytotoxic effect on MG63. The addition of TNC to EB1089-FHBP cotreatment enhanced the maturation of MG63, as supported by the greater alkaline phosphatase activity and OPN and OCN gene expression. Conclusion: TNC could serve as a promising carrier for FHBP, opening up possibilities for its application in bone regeneration.

Plain language summary

Nanoparticles (NPs) are often used in medicine because they have certain benefits over traditional drugs, such as increased delivery. Multiple NPs can be combined into hybrid NPs called nanocomplexes, which can have many positive effects. One application of nanomedicine is to encourage the repair of certain body tissues such as bones. Encouraging stem cells to differentiate into bone cells and immature bone cells to mature is key in this process. This study made a ternary nanocomplex (TNC), meaning it was comprised of three NPs. This TNC was designed to deliver a drug called (3S)1-fluoro-3-hydroxy-4-(oleoyloxy)butyl-1-phosphonate (FHBP), which has been shown to encourage the maturation and development of osteoblasts, a type of bone cell. The TNC was made up of silver NPs, which can kill bacteria; reduced graphene oxide, which enhances the production of bone cells; and titanium dioxide, which has shown effectiveness in wound healing and mixed results in bone tissue regeneration. This TNC was tested on a cell line that comes from a type of bone cancer called MG63. The TNC was found to not be toxic to these cells. TNC incorporation into FHBP treatment enhanced the maturation of MG63. This suggests that these TNCs could be an effective treatment to encourage bone repair following joint replacement surgeries.

Graphical abstract

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1. Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291(Pt 3), 677–680 (1993).
Medline CASGoogle Scholar
2. Mansell JP, Nowghani M, Pabbruwe M, Paterson I, Smith A, Blom A. Lysophosphatidic acid and calcitriol co-operate to promote human osteoblastogenesis: requirement of albumin-bound LPA. Prostaglandins Other Lipid Mediat. 95(1–4), 45–52 (2011).
Medline CASGoogle Scholar
3. Shiel AI, Ayre WN, Blom AW et al. Development of a facile fluorophosphonate-functionalised titanium surface for potential orthopaedic applications. J. Orthop. Translat. 23, 140–151 (2020).
MedlineGoogle Scholar
4. Mansell JP, Cooke M, Read M et al. Chitinase 3-like 1 expression by human (MG63) osteoblasts in response to lysophosphatidic acid and 1,25-dihydroxyvitamin D3. Biochimie 128, 193–200 (2016).
MedlineGoogle Scholar
5. Elkhenany H, Elkodous MA, Newby SD, El-Derby AM, Dhar M, El-Badri N. Tissue engineering modalities and nanotechnology. El-Badri N. (eds) In: Regenerative Medicine and Stem Cell Biology. Learning Materials in Biosciences. Springer, Cham, 289–322 (2020).
Google Scholar
6. El-Badri N, Elkhenany H. Toward the nanoengineering of mature, well-patterned and vascularized organoids. Nanomedicine 16(15), 1255–1258 (2021).
CASGoogle Scholar
7. Strub M, Van Bellinghen X, Fioretti F et al. Maxillary bone regeneration based on nanoreservoirs functionalized ε-polycaprolactone biomembranes in a mouse model of jaw bone lesion. Biomed. Res. Int. 2018, 7380389 (2018).
MedlineGoogle Scholar
8. Elkhateeb OM, Badawy MEI, Noreldin AE, Abou-Ahmed HM, El-Kammar MH, Elkhenany HA. Comparative evaluation of propolis nanostructured lipid carriers and its crude extract for antioxidants, antimicrobial activity, and skin regeneration potential. BMC Complement. Med. Ther. 22(1), 256 (2022).
Medline CASGoogle Scholar
9. Bonilla P, Hernandez J, Giraldo E et al. Human-induced neural and mesenchymal stem cell therapy combined with a curcumin nanoconjugate as a spinal cord injury treatment. Int. J. Mol. Sci. 22(11), 5966 (2021).
Medline CASGoogle Scholar
10. Elkhenany H, Bonilla P, Giraldo E et al. A hyaluronic acid demilune scaffold and polypyrrole-coated fibers carrying embedded human neural precursor cells and curcumin for surface capping of spinal cord injuries. Biomedicines 9(12), 1928 (2021).
Medline CASGoogle Scholar
11. Elkhenany H, Amelse L, Lafont A et al. Graphene supports in vitro proliferation and osteogenic differentiation of goat adult mesenchymal stem cells: potential for bone tissue engineering. J. Appl. Toxicol. 35(4), 367–374 (2015).
Medline CASGoogle Scholar
12. Elkhenany H, Bourdo S, Hecht S et al. Graphene nanoparticles as osteoinductive and osteoconductive platform for stem cell and bone regeneration. Nanomedicine 13(7), 2117–2126 (2017). •• This reference is interesting, as it investigates the effect of reduced graphene nanoparticles in in vitro and in vivo studies, supporting their potential to enhance bone regeneration. This aligns with the present research on ternary nanocomposite as a promising carrier for (3S)1-fluoro-3-hydroxy-4-(oleoyloxy)butyl-1-phosphonate in a bone regenerative setting.
Medline CASGoogle Scholar
13. Liu W, Luo H, Wei Q et al. Electrochemically derived nanographene oxide activates endothelial tip cells and promotes angiogenesis by binding endogenous lysophosphatidic acid. Bioact. Mater. 9, 92–104 (2022).
Medline CASGoogle Scholar
14. Malhotra R, Han Y, Nijhuis CA, Silikas N, Castro Neto AH, Rosa V. Graphene nanocoating provides superb long-lasting corrosion protection to titanium alloy. Dental Mat. 37(10), 1553–1560 (2021).
Medline CASGoogle Scholar
15. Du H, Zhu X, Fan C, Xu S, Wang Y, Zhou Y. Oxidative damage and OGG1 expression induced by a combined effect of titanium dioxide nanoparticles and lead acetate in human hepatocytes. Environ. Toxicol. 27(10), 590–597 (2012).
Medline CASGoogle Scholar
16. Saquib Q, Al-Khedhairy AA, Siddiqui MA, Abou-Tarboush FM, Azam A, Musarrat J. Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells. Toxicol. In Vitro 26(2), 351–361 (2012).
Medline CASGoogle Scholar
17. Hong F, Wu N, Zhao X et al. Titanium dioxide nanoparticle-induced dysfunction of cardiac hemodynamics is involved in cardiac inflammation in mice. J. Biomed. Mater. Res. A 104(12), 2917–2927 (2016).
Medline CASGoogle Scholar
18. Eldebany N, Abd Elkodous M, Tohamy H et al. Gelatin loaded titanium dioxide and silver oxide nanoparticles: implication for skin tissue regeneration. Biol. Trace Elem. Res. 199(10), 3688–3699 (2021).
Medline CASGoogle Scholar
19. Nikpasand A, Parvizi MR. Evaluation of the effect of titanium dioxide nanoparticles/gelatin composite on infected skin wound healing; an animal model study. Bull. Emerg. Trauma 7(4), 366–372 (2019).
MedlineGoogle Scholar
20. Kubota S, Johkura K, Asanuma K et al. Titanium oxide nanotubes for bone regeneration. J. Mater. Sci. Mater. Med. 15(9), 1031–1035 (2004).
Medline CASGoogle Scholar
21. Souza W, Piperni SG, Laviola P et al. The two faces of titanium dioxide nanoparticles bio-camouflage in 3D bone spheroids. Sci. Rep. 9(1), 9309 (2019).
Medline CASGoogle Scholar
22. Niska K, Pyszka K, Tukaj C, Wozniak M, Radomski MW, Inkielewicz-Stepniak I. Titanium dioxide nanoparticles enhance production of superoxide anion and alter the antioxidant system in human osteoblast cells. Int. J. Nanomed. 10, 1095–1107 (2015).
Medline CASGoogle Scholar
23. Zhang Y, Yu W, Jiang X, Lv K, Sun S, Zhang F. Analysis of the cytotoxicity of differentially sized titanium dioxide nanoparticles in murine MC3T3-E1 preosteoblasts. J. Mater. Sci. Mater. Med. 22(8), 1933–1945 (2011).
Medline CASGoogle Scholar
24. Quinn J, McFadden R, Chan C-W, Carson L. Titanium for orthopedic applications: an overview of surface modification to improve biocompatibility and prevent bacterial biofilm formation. iScience 23(11), 101745 (2020).
Medline CASGoogle Scholar
25. Geetha M, Singh AK, Asokamani R, Gogia AK. Ti based biomaterials, the ultimate choice for orthopaedic implants – a review. Prog. Mater. Sci. 54(3), 397–425 (2009).
CASGoogle Scholar
26. Nie BE, Huo S, Qu X et al. Bone infection site targeting nanoparticle-antibiotics delivery vehicle to enhance treatment efficacy of orthopedic implant related infection. Bioact. Mater. 16, 134–148 (2022).
Medline CASGoogle Scholar
27. Qing Y, Cheng L, Li R et al. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int. J. Nanomed. 13, 3311–3327 (2018).
Medline CASGoogle Scholar
28. Khalandi B, Asadi N, Milani M et al. A review on potential role of silver nanoparticles and possible mechanisms of their actions on bacteria. Drug Res. (Stuttg.) 67(2), 70–76 (2017).
Medline CASGoogle Scholar
29. Klueh U, Wagner V, Kelly S, Johnson A, Bryers JD. Efficacy of silver-coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation. J. Biomed. Mater. Res. 53(6), 621–631 (2000).
Medline CASGoogle Scholar
30. Long YM, Hu LG, Yan XT et al. Surface ligand controls silver ion release of nanosilver and its antibacterial activity against Escherichia coli. Int. J. Nanomed. 12, 3193–3206 (2017).
Medline CASGoogle Scholar
31. Gon S, Faulkner MJ, Beckwith J. In vivo requirement for glutaredoxins and thioredoxins in the reduction of the ribonucleotide reductases of Escherichia coli. Antioxid. Redox Signal. 8(5–6), 735–742 (2006).
Medline CASGoogle Scholar
32. Roy S, Martel J, Tenenhouse HS. Comparative effects of 1, 25‐dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25‐hydroxyvitamin D3‐24‐hydroxylase. J. Bone Miner. Res. 10(12), 1951–1959 (1995).
Medline CASGoogle Scholar
33. Carlberg C, Mathiasen IS, Saurat J-H, Binderup L. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. J. Steroid Biochem. Mol. Biol. 51(3-4), 137–142 (1994).
Medline CASGoogle Scholar
34. Binderup L, Carlberg C, Kissmeyer A, Latini S, Mathiasen I, Hansen CM. The need for new vitamin D analogues: mechanisms of action and clinical applications. In: Vitamin D: A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. Proceedings of the Ninth Workshop on Vitamin D, Orlando, Florida, USA, May 28–June 2, 1994. Berlin, Boston: De Gruyter. Norman ABouillon RThomasset M (Eds). 55–63 (1994). https://doi.org/10.1515/9783110882513-022
Google Scholar
35. Staudenmaier L. Verfahren zur darstellung der graphitsäure. Berichte der deutschen chemischen Gesellschaft 31(2), 1481–1487 (1898).
CASGoogle Scholar
36. Abd Elkodous M, S El-Sayyad G, Abdel Maksoud MIA et al. Nanocomposite matrix conjugated with carbon nanomaterials for photocatalytic wastewater treatment. J. Hazard. Mater. 410, 124657 (2021).
MedlineGoogle Scholar
37. Abd Elkodous M, El-Sayyad GS, Youssry SM et al. Carbon-dot-loaded CoxNi1‐xFe₂O₄; x = 0.9/SiO₂/TiO₂ nanocomposite with enhanced photocatalytic and antimicrobial potential: an engineered nanocomposite for wastewater treatment. Sci. Rep. 10(1), 11534 (2020).
MedlineGoogle Scholar
38. Baldwin F, Craig TJ, Shiel AI, Cox T, Lee K, Mansell JP. Polydopamine-lysophosphatidate-functionalised titanium: a novel hybrid surface finish for bone regenerative applications. Molecules 25(7), 1583 (2020).
Medline CASGoogle Scholar
39. Neary G, Blom AW, Shiel AI, Wheway G, Mansell JP. Development and biological evaluation of fluorophosphonate-modified hydroxyapatite for orthopaedic applications. J. Mater. Sci Mat. Med. 29(8), 1–10 (2018).
CASGoogle Scholar
40. Lancaster ST, Blackburn J, Blom A, Makishima M, Ishizawa M, Mansell JP. 24, 25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation. Steroids 83, 52–61 (2014). •• This reference is interesting, as it investigates the integrative potential of vitamin D3 and lysophosphatidic acid in promoting osteoblast maturation. Understanding the cooperative effects of different molecules on cell maturation can provide insights relevant to the present study.
Medline CASGoogle Scholar
41. Hou J, Lan X, Shi J et al. A mild and simple method to fabricate commercial TiO₂ (P25) and C60 composite for highly enhancing H₂ generation. Int. J. Hydrogen Energy 45(4), 2852–2861 (2020).
CASGoogle Scholar
42. Abd Elkodous M, El-Sayyad GS, Mohamed AE et al. Layer-by-layer preparation and characterization of recyclable nanocomposite (CoxNi1-xFe₂O₄; X = 0.9/SiO₂/TiO₂). J. Mater. Sci. 30(9), 8312–8328 (2019).
Google Scholar
43. Xu D, Wang C, Wu J et al. Effects of low-concentration graphene oxide quantum dots on improving the proliferation and differentiation ability of bone marrow mesenchymal stem cells through the Wnt/β-catenin signaling pathway. ACS Omega 7(16), 13546–13556 (2022).
Medline CASGoogle Scholar
44. Li C, Li Z, Zhang Y, Fathy AH, Zhou M. The role of the Wnt/β-catenin signaling pathway in the proliferation of gold nanoparticle-treated human periodontal ligament stem cells. Stem Cell Res. Ther. 9(1), 1–10 (2018).
MedlineGoogle Scholar
45. Dallas SL, Bonewald LF. Dynamics of the transition from osteoblast to osteocyte. Ann. NY Acad. Sci. 1192(1), 437–443 (2010). • This reference is interesting, as it clarifies the molecular basis of osteoblast maturation and transition to osteocyte. The information provided can help contextualize the present study's focus on enhancing the maturation of MG63 cells.
Medline CASGoogle Scholar
46. Filova E, Suchý T, Sucharda Z et al. Support for the initial attachment, growth and differentiation of MG-63 cells: a comparison between nano-size hydroxyapatite and micro-size hydroxyapatite in composites. Int. J. Nanomed. 9, 3687 (2014).
MedlineGoogle Scholar
47. Ryu JH, Messersmith PB, Lee H. Polydopamine surface chemistry: a decade of discovery. ACS Appl. Mater. Interfaces 10(9), 7523–7540 (2018).
Medline CASGoogle Scholar
48. Choi YS, Hong YJ, Hur J et al. Bone nodule formation of MG63 cells is increased by the interplay of signaling pathways cultured on vitamin D3‐entrapped calcium phosphate films. Anim. Cells Syst. (Seoul) 13(4), 363–370 (2009).
CASGoogle Scholar
49. Frost R, Jönsson GE, Chakarov D, Svedhem S, Kasemo B. Graphene oxide and lipid membranes: interactions and nanocomposite structures. Nano Lett. 12(7), 3356–3362 (2012).
Medline CASGoogle Scholar
50. Chen J, Zhou G, Chen L, Wang Y, Wang X, Zeng S. Interaction of graphene and its oxide with lipid membrane: a molecular dynamics simulation study. J. Phys. Chem. C Nanomater. Interfaces 120(11), 6225–6231 (2016).
CASGoogle Scholar
51. Tsuzuki K, Okamoto Y, Iwasa S, Ishikawa R, Sandhu A, Tero R. Reduced graphene oxide as the support for lipid bilayer membrane. J. Phys. Conf. Ser. 352(1), 12016 (2012).
Google Scholar
52. Queffelec C, Petit M, Janvier P, Knight DA, Bujoli B. Surface modification using phosphonic acids and esters. Chem. Rev. 112(7), 3777–3807 (2012).
Medline CASGoogle Scholar
53. Blair HC, Larrouture QC, Li Y et al. Osteoblast differentiation and bone matrix formation in vivo and in vitro. Tissue Eng. Part B Rev. 23(3), 268–280 (2017).
Medline CASGoogle Scholar
54. Elkhenany H, Amelse L, Caldwell M, Abdelwahed R, Dhar M. Impact of the source and serial passaging of goat mesenchymal stem cells on osteogenic differentiation potential: implications for bone tissue engineering. J. Anim. Sci. Biotechnol. 7(1), 1–13 (2016).
MedlineGoogle Scholar
55. Luu HH, Song WX, Luo X et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J. Orthop. Res. 25(5), 665–677 (2007).
Medline CASGoogle Scholar
56. Tsao YT, Huang YJ, Wu HH, Liu YA, Liu YS, Lee OK. Osteocalcin mediates biomineralization during osteogenic maturation in human mesenchymal stromal cells. Int. J. Mol. Sci. 18(1), 1–13 (2017).
Google Scholar
57. MacDonald AF, Trotter RD, Griffin CD et al. Genetic profiling of human bone marrow and adipose tissue-derived mesenchymal stem cells reveals differences in osteogenic signaling mediated by graphene. J. Nanobiotechnol. 19, 1–18 (2021).
MedlineGoogle Scholar
58. Kang MS, Jeong SJ, Lee SH et al. Reduced graphene oxide coating enhances osteogenic differentiation of human mesenchymal stem cells on Ti surfaces. Biomater. Res. 25(1), 1–9 (2021). •• The authors investigated the effect of reduced graphene on the osteogenic differentiation of stem cells, which is relevant to the present study, as the authors are exploring the enhanced maturation of MG63 cells using ternary nanocomposite as a carrier.
MedlineGoogle Scholar
59. Song J-W, Fan L-W. Temperature dependence of the contact angle of water: a review of research progress, theoretical understanding, and implications for boiling heat transfer. Adv. Colloid Interface Sci. 288, 102339 (2021).
Medline CASGoogle Scholar
60. Strnad G, Chirila N, Petrovan C, Russu O. Contact angle measurement on medical implant titanium based biomaterials. Procedia Technol. 22, 946–953 (2016).
Google Scholar

Vol. 18, No. 21

Supplemental Materials

Metrics

Downloaded 39 times

History

Received 20 April 2023

Accepted 30 August 2023

Published online 10 October 2023

Published in print September 2023

Information

Keywords

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/nnm-2023-0117

Financial disclosure

H Elkhenany would like to acknowledge the British Academy of Medical Sciences for the financial support of her visit to the Department of Applied Sciences, the University of the West of England (Bristol, UK), through a Daniel Turnberg Travel Fellowship. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

PDF download